Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Young Adult Oncology”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00470275
What this trial is testing

Cytarabine in Treating Young Patients With Recurrent or Refractory Ewing's Sarcoma

Who this might be right for
Sarcoma
Children's Oncology Group 10
Not applicableActive Not RecruitingNCT06737172
What this trial is testing

Functional and Structural Outcomes Following Childhood Bone or Soft Tissue Sarcomas of the Lower Extremity

Who this might be right for
Soft Tissue Sarcoma of the Lower ExtremityBone Sarcoma of the Lower ExtremityChildhood and Adolescent Cancer
Technical University of Munich 18
Testing effectiveness (Phase 2)Active Not RecruitingNCT02867592
What this trial is testing

Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors

Who this might be right for
Adrenal Cortical CarcinomaAlveolar Soft Part SarcomaCentral Nervous System Neoplasm+41 more
National Cancer Institute (NCI) 109
Testing effectiveness (Phase 2)Looking for participantsNCT04925609
What this trial is testing

Brigatinib in Pediatric and Young Adult Patients With ALK+ ALCL, IMT or Other Solid Tumors

Who this might be right for
Anaplastic Large Cell Lymphoma, ALK-PositiveInflammatory Myofibroblastic TumorOther Solid Tumor
Princess Maxima Center for Pediatric Oncology 65
Not applicableNot Yet RecruitingNCT07681258
What this trial is testing

Asciminib Safety and Efficacy in Young Adults With Chronic Myeloid Leukemia in the Gulf Region

Who this might be right for
Chronic Myeloid Leukemia
Novartis Pharmaceuticals 80
Early research (Phase 1)Ended earlyNCT02412475
What this trial is testing

Epigenetic Reprogramming in Relapse AML

Who this might be right for
Leukemia, Acute Myeloid
Michael Burke 3
Testing effectiveness (Phase 2)Study completedNCT00179790
What this trial is testing

Reduced Intensity Transplant Using Extracorporeal Photopheresis

Who this might be right for
LeukemiaCancer
Ann & Robert H Lurie Children's Hospital of Chicago 22
Early research (Phase 1)Study completedNCT01259479
What this trial is testing

Satraplatin in Children and Young Adults With Refractory Solid Tumors Including Brain Tumors

Who this might be right for
Solid TumorsBrain TumorsBrain Metastases
National Cancer Institute (NCI) 9
Large-scale testing (Phase 3)Study completedNCT00337818
What this trial is testing

Human Papillomavirus (HPV) Vaccine Consistency and Non-inferiority Trial in Young Adult Women

Who this might be right for
Papillomavirus Type 16/18 InfectionCervical Intraepithelial Neoplasia
GlaxoSmithKline 770
Not applicableNot Yet RecruitingNCT07802054
What this trial is testing

Messages That Motivate: Communicating Alcohol-Related Breast Cancer Risk to Young Adult Women

Who this might be right for
CommunicationMessage PerceptionAlcohol+2 more
Ohio State University Comprehensive Cancer Center 900
Testing effectiveness (Phase 2)WithdrawnNCT01048086
What this trial is testing

90Y DOTA/Retinoic Acid for Neuroblastoma and Neuroendocrine Tumor (NET)

Who this might be right for
NeuroblastomaNeuroendocrine Tumor
University of Iowa
Early research (Phase 1)Study completedNCT02596503
What this trial is testing

Eribulin in Combination With Oral Irinotecan for Adolescent and Young Adult Patients With Relapsed or Refractory Solid Tumors

Who this might be right for
Relapsed Solid TumorsRefractory Solid Tumors
University of Colorado, Denver 2
Large-scale testing (Phase 3)Study completedNCT00819351
What this trial is testing

ALL2008 Protocol for Childhood Acute Lymphoblastic Leukemia Intermittent Versus Continuous PEG Asparaginase

Who this might be right for
Acute Lymphoblastic Leukemia
Rigshospitalet, Denmark 650
Early research (Phase 1)Study completedNCT02057445
What this trial is testing

3rd Party LMP1/2-Specific Cytotoxic T Lymphocytes for EBV-Associated Lymphoma

Who this might be right for
Non-Hodgkins LymphomaHodgkins LymphomaLymphoproliferative Disorder
New York Medical College 1
Not applicableStudy completedNCT01901237
What this trial is testing

Yoga for Adolescent and Young Adult Non-Curative Cancer Patients

Who this might be right for
Advanced Cancer
Rob Rutledge 5
Not applicableStudy completedNCT03482778
What this trial is testing

Measuring Health Related Quality of Life in AYAs

Who this might be right for
OncologyQuality of Life
Wake Forest University Health Sciences 165
Early research (Phase 1)Study completedNCT01593696
What this trial is testing

Anti-CD19 White Blood Cells for Children and Young Adults With B Cell Leukemia or Lymphoma

Who this might be right for
ALLB Cell LymphomaLeukemia+2 more
National Cancer Institute (NCI) 53
Not applicableLooking for participantsNCT05839379
What this trial is testing

Targeted Pediatric High-Grade Glioma Therapy

Who this might be right for
High Grade GliomaDiffuse Intrinsic Pontine GliomaAnaplastic Astrocytoma+6 more
Nationwide Children's Hospital 350
Not applicableNot Yet RecruitingNCT07837089
What this trial is testing

Increasing Engagement With Digital Behavioral Health

Who this might be right for
Cancer Survivorship
Hackensack Meridian Health 13
Not applicableLooking for participantsNCT06748820
What this trial is testing

E-CANE: a National Program of Remote Health Education Workshops

Who this might be right for
Neoplasms
Centre Hospitalier Universitaire de Nice 48
Next Page